From
the
desk
of
Bill
Ramey
1/24/17
COMMENTARY & OPINION
Robert F Kennedy’s devastating quotes on vaccines and the CDC
Thursday,
January 26, 2017 7:05
Boom—how
and why the CDC can foist toxic vaccines on the American people
By Jon Rappoport
From
Kennedy’s video presentation, “7 Minutes on the CDC,” Anne Dachel (Age of
Autism) has transcribed excerpts. This is explosive material, particularly
because there is a chance Kennedy will head up an investigation of vaccine
safety under Trump.
Kennedy
understands the inherent conflict of interest at the CDC, which operates as a
vaccine sales and marketing company, while at the same time posing as a neutral
scientific body that assesses vaccine safety—AND OF COURSE, THE CDC PRESENTS AN
EVER-EXPANDING SCHEDULE OF “NECESSARY” VACCINES TO THE AMERICAN PEOPLE.
Think
of it: the CDC has the power—backed by federal and state governments, and
supported by the fake-news media—to buy and sell vaccines, while deciding how
many vaccines the population should submit to. What salesman wouldn’t want to
work for an outfit like that?
Here
are Kennedy’s remarks. Read them, study them, and learn the truth:
“The
CDC is a very troubled agency, and it’s not just me saying that. There have
been four separate, intensive federal investigations by the United States
Congress—a three year investigation, 2001, 2002, 2003, by the United States
Senate, Tom Coburn’s committee, by the Inspector General of HHS in 2008, by the
Office Integrity in 2014. All of them have painted the CDC as a cesspool of
corruption, of an agency that has become an absolute subsidiary of the
pharmaceutical industry, and that has become a sock puppet, a spokesperson, a
shill for the industry.”
“CDC
is not an independent agency. It is a vaccine company. CDC owns over twenty
vaccine patents. It sells about $4.6 billion of vaccines every year. And its
primary metric for success in all the departments in the agency are vaccine
sales. The groups, for example the Immunization Safety Office, where the
scientists who are supposed to be looking at efficacy and safety in vaccines,
they are no longer a public service…agency. They are subsumed in that metric:
We have to sell as many of these things as possible. And so they do things to
their science to make sure that nothing interferes—no information—interferes
with sales.
“Now
there are two divisions of the vaccine branch where we worry about the
corruption. The first one is called the Advisory Committee on Immunization
Practices. That is the committee that makes the decision about what new
vaccines to add to the schedule.”
“When
I was a boy, I got three vaccines. My children got sixty-nine vaccines. It
changed in 1989.”
“Why
did it change in 1989?”
“Because
in 1986, Congress, [was] drowning in pharmaceutical industry money—pharma puts
more money into lobbying than any other industry—Pharmaceutical companies have
more lobbyists on Capitol Hill than there are Congress people.”
“Do
you think oil and gas has big influence in the Capitol? Well, that’s the next
biggest. The pharmaceutical industry puts twice into lobbying, double the
amount that the oil and gas, and four times what defense and aero space put in.
So they control Congress.”
“In
1986, Congress passed the Vaccine Act, and there were good reasons for them to
pass it. …At that time vaccine companies were being sued and were threatening
to stop making vaccines. [Congress] said, okay, we’re going to insulate them
from lawsuits. They made it illegal to sue a vaccine company in this country,
no matter how reckless the behavior, no matter how negligent, no matter how
toxic the product, no matter how grievous the injury to the child, you cannot
sue.”
“You
know how badly the pharmaceutical industry behaves when they are being sued,
when there’s a whole bar of lawyers who spend their whole life looking for ways
to sue the pharmaceutical industry and tell these stories to juries, and how
many billions every year are won from that industry.”
“What
do you think would happen if all of a sudden, all the lawyers disappeared, all
the class action suits, all the multi district litigation, all the depositions,
all the document searches, the discovery? Just gone. Nobody can sue. You can
make anything you want.”
“And
then they made it so that it was much easier to get a vaccine on the schedule
than it was to get a pharmaceutical into the market. There’s no double blind
placebo studies. They’re all fast tracked into the market place.”
“The
decision is made by this group, the Advisory Committee on Immunization
Practices. And you’d hope that the people who would serve on that committee
would be kind of nerdy scientists who are narrowly focused on public health
outcomes, but that’s not who they are. The people who serve on that committee,
almost all of them, have strong financial ties to the pharmaceutical industry.”
“I’ll
give you an example of how this committee works. In 1999, Paul Offit sat on
that committee. And when you go to this committee, when you go to their
meetings, the Advisory Committee on Immunization Practices is in one room, and
then there’s a press deck in the next room. You have a whole bunch of seats
there with guys who look like me, in suits. They’re Wall Street analysts,
pharmaceutical analysts. They’re waiting to hear the decision. And as soon as
they come out and announce which new vaccines they put on the schedule, those
guys run out in the hallway and get on their cell phones, and you can watch the
stocks spike. So it’s become an economic enterprise.”
“Paul
Offit sat on the committee in 1999 that added the rota virus vaccine to the
schedule. He owned a patent to a rota virus vaccine. He was then able to sell
his vaccine to Merck for $186 million. He pocketed something around $29
million. He’s never allowed anybody to ask him exactly how much, but according
to the formula that they use, he would have gotten at least $29 million.”
“That
caused a little bit of a scandal in Washington,
and the Inspector General of HHS was sent to investigate it. They did a
complete investigation of the Advisory Committee on Immunization Practices, and
what they found, what they concluded was what he did was not illegal under CDC
rules. Sixty-four percent of the people who sat on that committee had conflicts
that were similar to Paul Offit, and ninety-seven percent might have conflicts
because the rest of them never made out their conflict of interest forms. And
nobody ever made them do it.”
“It’s
very difficult when those kinds of shenanigans are going on. The American
people have faith that all of these new vaccines that were added, beginning in
1989, are put there solely because this committee is concerned with public
health.”
Got
it? This is four years’ worth of university political-science curriculum in
seven minutes. Well, the actual title is politicized science.
Every
American who can read should read it.
This
is what is really going on at America’s
number-one public health agency—the agency that is also a corporation.
This
is war against the American people from within.
Filed
under: Uncategorized Jon Rappoport has worked as a free-lance
investigative reporter for over 30 years. http://nomorefakenews.com/
Ramey
comment:
WOW! THE DONALD IS, NOT ONLY DERAILING THE GRAVY
TRAIN --- HE'S RIPPING OUT THE RAILS!
THIS ARTICLE SHOULD GO VIRAL.
SEE WHO'S FIGHTING HIM IN THE NEXT ARTICLE.
Republican traitor Paul Ryan now trying to protect Big Pharma from Trump’s monopoly-dismantling reforms
10KViews
(Natural News) Though on the surface it
may seem like President Donald
Trump has it good, politically: He’s a GOP president at a time when he’s
also got a Republican
majority in Congress. And while Democrats will always be Trump’s
biggest political obstructionists, he’s going to get far too much pushback from
establishment Republicans who still don’t understand they were given clear
mandates by the American people to get certain things done.
One
of those things involves dramatically reforming health care—and not like President
Obama and the Democrats “reformed” it when they ruled Congress and the
White House, a la
Obamacare. It’s obvious that some Republican leaders don’t get
this, and one of them may be House Speaker Paul Ryan, R-Wis.
Ryan,
for some reason, appears to be picking a fight with Trump and Vice President
Mike Pence over the administration’s pledge to tackle the corruption of Big
Pharma. Every American adult who has had to pay for medications over the last
several years knows that they have gone up in price dramatically, and that
there seems to be nothing stopping drug makers from boosting prices even on
drugs that have been around for a long time. (RELATED: Stay up to date with the
Trump administration at WhiteHouse.news)
What’s
more, the price increases are
only going to get
worse this year, as Trump predicted.
In
his first press conference in recent days, Trump—speaking at Trump Tower
in New York City—promised
pharmaceutical industry reforms including proper bidding on prices, among other
measures, moving forward, Breitbart
reported.
“We
have to get our drug industry coming back,” he said. “Our drug industry has
been disastrous. They’re leaving left and right. They supply our drugs but they
don’t make them here, to a large extent. And the other thing we have to do is
create new bidding procedures for the drug industry, because they’re getting
away with murder. Pharma has a lot of lobbies, a lot of lobbyists, a lot of
power.”
He
went on to note that currently, there is very little bidding going on regarding
drugs, even though Americans and the U.S. government are the largest consumers
of pharmaceutical drugs.
“We’re
going to start bidding,” said Trump. “We’re going to save billions of dollars
over a period of time.”
Trump
doubled down on his criticisms of Big Pharma later, in
an interview with the Washington
Post, saying that Big Pharma was “politically protected, but
not anymore.”
According
to Fortune,
Trump’s comments sent
the pharmaceutical industry into a financial tailspin. Enter the donor
class’ favorite House Speaker, Ryan.
In
response, Ryan told Mike Allen of Axios that he wants to “have more
conversations about” the president’s efforts to crack down on Big Pharma
corruption before it actually happens.
For
the record, according to money-in-politics watchdog MapLight, the
“Pharmaceuticals/Health Products” industries are one of the top 10 donors to
Ryan, contributing
$381,979 through June 30, 2016.
“I
believe that the current premium support system with Part D works extremely
well,” Ryan said. “I think there’s some real success stories … and I think we
need to tell that story.”
When
Allen asked if that also meant telling the president such stories, Ryan replied
that it needs to be told to “a lot of people.”
He
added: “I think [incoming Health and Human Services Secretary] Tom Price
understands this issue extremely well.”
When
he was asked about Trump’s comments that Big Pharma was politically protected,
“but not anymore,” Ryan replied, “I don’t speak like that, generally speaking.
I’m always looking for win-win situations, and I believe there’s a lot more we
can do to bring down the price of drugs.” (RELATED: Stay current on this and
other issues dealing with the pharmaceutical
industry at BigPharmaNews.com)
The
tension is more of the kind we’ve seen since the nationalist/populist Trump—the
first real president “for all the people” in several generations who wants to
stand up to the globalists, crony capitalists and corporatists—began rubbing up
against the elitists who ‘run things.’
The
Washington
political class has never had to deal with anyone like Trump as president. He
is not one of them,
so he doesn’t view issues and problems through the same politically compromised
prism as they do. Trump’s idea of “win-win” isn’t a “bipartisan agreement” per
se, it’s any deal that helps as many Americans as possible (especially those
who, up to now, have not had a voice in D.C.) while saving the government money
and making it more efficient.
The
ruling elite see “win-win” as anything that makes it appear as though
they’re ‘doing something for the people,’ while actually doing something for
the donors who keep them in power.
Big
difference.
J.D.
Heyes is a senior writer for Natural
News
and News Target, as well as editor of The
National Sentinel.
No comments:
Post a Comment